0001775697-22-000667.txt : 20220728 0001775697-22-000667.hdr.sgml : 20220728 20220728062529 ACCESSION NUMBER: 0001775697-22-000667 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220728 DATE AS OF CHANGE: 20220728 PERIOD START: 20230228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY MELLON RESEARCH GROWTH FUND, INC. CENTRAL INDEX KEY: 0000030162 IRS NUMBER: 132641740 STATE OF INCORPORATION: NY FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-01899 FILM NUMBER: 221112671 BUSINESS ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 BUSINESS PHONE: 2129226400 MAIL ADDRESS: STREET 1: C/O BNY MELLON INVESTMENT ADVISER, INC. STREET 2: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS RESEARCH GROWTH FUND, INC. DATE OF NAME CHANGE: 20181030 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS RESEARCH GROWTH FUND, INC DATE OF NAME CHANGE: 20110606 FORMER COMPANY: FORMER CONFORMED NAME: DREYFUS RESEARCH GROWTH FUND INC DATE OF NAME CHANGE: 20081201 0000030162 S000000071 BNY Mellon Research Growth Fund, Inc. C000000108 Class Z DREQX C000069523 Class A DWOAX C000069524 Class C DWOCX C000069525 Class I DWOIX C000127666 Class Y DRYQX NPORT-P 1 primary_doc.xml NPORT-P false 0000030162 XXXXXXXX S000000071 C000000108 C000069523 C000069524 C000069525 C000127666 BNY Mellon Research Growth Fund, Inc. 811-01899 0000030162 549300FY88RGTLBBN315 240 Greenwich Street New York 10286 212 495 1784 BNY Mellon Research Growth Fund, Inc. S000000071 549300FY88RGTLBBN315 2023-02-28 2022-05-31 N 1576854798.42 1690228.96 1575164569.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 UST AMAZON.COM INC ZXTILKJKG63JELOEG630 AMAZON.COM INC 023135106 48749.00 NS USD 117201858.31 7.4406103706471 Long EC CORP US N 1 N N N ALCOA CORP 549300T12EZ1F6PWWU29 ALCOA CORP 013872106 498178.00 NS USD 30747546.16 1.9520211891599 Long EC CORP US N 1 N N N SALESFORCE INC RCGZFPDMRW58VJ54VR07 SALESFORCE INC 79466L302 163383.00 NS USD 26180491.92 1.6620797869377 Long EC CORP US N 1 N N N APPLIED MATERIALS INC 41BNNE1AFPNAZELZ6K07 APPLIED MATERIALS INC 038222105 247335.00 NS USD 29009922.15 1.841707381721 Long EC CORP US N 1 N N N LULULEMON ATHLETICA INC 549300D9GZ4BMLDW5T40 LULULEMON ATHLETICA INC 550021109 28476.00 NS USD 8334640.44 0.5291282321603 Long EC CORP US N 1 N N N ROCKWELL AUTOMATION INC VH3R4HHBHH12O0EXZJ88 ROCKWELL AUTOMATION INC 773903109 64818.00 NS USD 13819197.60 0.8773177017775 Long EC CORP US N 1 N N N SEAGEN INC N/A SEAGEN INC 81181C104 110853.00 NS USD 15040535.04 0.9548548343209 Long EC CORP US N 1 N N N HORIZON THERAPEUTICS PLC 529900P0GSQ79OOZEV53 HORIZON THERAPEUTICS PLC N/A 246083.00 NS USD 22071184.27 1.4011986238089 Long EC CORP US N 1 N N ALIGN TECHNOLOGY INC 549300N5YSE0U3LCP840 ALIGN TECHNOLOGY INC 016255101 33307.00 NS USD 9247355.48 0.5870723389347 Long EC CORP US N 1 N N N ZEBRA TECHNOLOGIES CORP PO0I32GKZ3HZMMDPZZ08 ZEBRA TECHNOLOGIES CORP 989207105 75332.00 NS USD 25476529.08 1.6173884033421 Long EC CORP US N 1 N N N ESTEE LAUDER COS INC/THE 549300VFZ8XJ9NUPU221 ESTEE LAUDER COS INC/THE 518439104 42539.00 NS USD 10832556.35 0.68770949779 Long EC CORP US N 1 N N N HUBSPOT INC 529900BLNVEW0MVKJB37 HUBSPOT INC 443573100 52776.00 NS USD 17821927.44 1.1314327268108 Long EC CORP US N 1 N N N INGERSOLL RAND INC 5299004C02FMZCUOIR50 INGERSOLL RAND INC 45687V106 576509.00 NS USD 27182399.35 1.7256863109432 Long EC CORP US N 1 N N N WALT DISNEY CO/THE 549300GZKULIZ0WOW665 WALT DISNEY CO/THE 254687106 68441.00 NS USD 7558624.04 0.4798624973256 Long EC CORP US N 1 N N N ZOOM VIDEO COMMUNICATIONS INC 549300T9GCHU0ODOM055 ZOOM VIDEO COMMUNICATIONS INC 98980L101 70582.00 NS USD 7584035.90 0.4814757801846 Long EC CORP US N 1 N N N REPLIGEN CORP 54930006QJ0T5AUO1E71 REPLIGEN CORP 759916109 75332.00 NS USD 12389854.04 0.7865752112649 Long EC CORP US N 1 N N N ALPHABET INC 5493006MHB84DD0ZWV18 ALPHABET INC 02079K107 53924.00 NS USD 122988780.72 7.8079956281751 Long EC CORP US N 1 N N N EQT CORP 4NT01YGM4X7ZX86ISY52 EQT CORP 26884L109 1109676.00 NS USD 52953738.72 3.361790872312 Long EC CORP US N 1 N N N UBER TECHNOLOGIES INC 549300B2FTG34FILDR98 UBER TECHNOLOGIES INC 90353T100 499598.00 NS USD 11590673.60 0.7358388973904 Long EC CORP US N 1 N N N APPLE INC HWUPKR0MPOU8FGXBT394 APPLE INC 037833100 839562.00 NS USD 124960408.08 7.9331652389082 Long EC CORP US N 1 N N N ANSYS INC 549300VJV8H15Z5FJ571 ANSYS INC 03662Q105 73766.00 NS USD 19205715.76 1.2192831233236 Long EC CORP US N 1 N N N SYSCO CORP 5RGWIFLMGH3YS7KWI652 SYSCO CORP 871829107 324441.00 NS USD 27311443.38 1.7338787266757 Long EC CORP US N 1 N N N MICROSOFT CORP INR2EJN1ERAN0W5ZP974 MICROSOFT CORP 594918104 531182.00 NS USD 144412450.34 9.1680865060028 Long EC CORP US N 1 N N N TRANE TECHNOLOGIES PLC 549300BURLR9SLYY2705 TRANE TECHNOLOGIES PLC N/A 203044.00 NS USD 28032254.64 1.7796397394597 Long EC CORP IE N 1 N N N HOWMET AEROSPACE INC 549300HO5WFZUT5N2T22 HOWMET AEROSPACE INC 443201108 566623.00 NS USD 20268104.71 1.2867293426329 Long EC CORP US N 1 N N N TWILIO INC 5493004W8TRGD63APX93 TWILIO INC 90138F102 316492.00 NS USD 33285463.64 2.1131419716614 Long EC CORP US N 1 N N N NETFLIX INC 549300Y7VHGU0I7CE873 NETFLIX INC 64110L106 49733.00 NS USD 9819283.52 0.6233814364784 Long EC CORP US N 1 N N N INTUITIVE SURGICAL INC 54930052SRG011710797 INTUITIVE SURGICAL INC 46120E602 103038.00 NS USD 23455570.32 1.4890869674678 Long EC CORP US N 1 N N N PELOTON INTERACTIVE INC 5493002YS021166W0339 PELOTON INTERACTIVE INC 70614W100 1208578.00 NS USD 16871748.88 1.0711102323602 Long EC CORP US N 1 N N CROWDSTRIKE HOLDINGS INC 549300YBY08K9KM4HX32 CROWDSTRIKE HOLDINGS INC 22788C105 83317.00 NS USD 13329886.83 0.8462535971444 Long EC CORP US N 1 N N N MARVELL TECHNOLOGY INC N/A MARVELL TECHNOLOGY INC 573874104 342209.00 NS USD 20241662.35 1.2850506380383 Long EC CORP US N 1 N N N CINTAS CORP 549300QVUQTTKMTE0G41 CINTAS CORP 172908105 59643.00 NS USD 23757596.19 1.5082612096934 Long EC CORP US N 1 N N N CHEWY INC 254900NPQSTG9I422879 CHEWY INC 16679L109 326550.00 NS USD 8098440.00 0.5141329456627 Long EC CORP US N 1 N N EDWARDS LIFESCIENCES CORP YA13X31F3V31L8TMPR58 EDWARDS LIFESCIENCES CORP 28176E108 257357.00 NS USD 25954453.45 1.6477296374751 Long EC CORP US N 1 N N N DANAHER CORP S4BKK9OTCEWQ3YHPFM11 DANAHER CORP 235851102 87299.00 NS USD 23031222.18 1.4621470433337 Long EC CORP US N 1 N N N ELI LILLY & CO FRDRIPF3EKNDJ2CQJL29 ELI LILLY & CO 532457108 151886.00 NS USD 47607147.84 3.022360251305 Long EC CORP US N 1 N N N BOOKING HOLDINGS INC FXM8FAOHMYDIPD38UZ17 BOOKING HOLDINGS INC 09857L108 16166.00 NS USD 36269390.96 2.3025778806359 Long EC CORP US N 1 N N N DATADOG INC 549300F6JNO0KRPO1K63 DATADOG INC 23804L103 148017.00 NS USD 14119341.63 0.8963724745815 Long EC CORP US N 1 N N N AMETEK INC 549300WZDEF9KKE40E98 AMETEK INC 031100100 218726.00 NS USD 26568647.22 1.6867219930618 Long EC CORP US N 1 N N N BLOCK INC 549300OHIIUWSTIZME52 BLOCK INC 852234103 559047.00 NS USD 48922202.97 3.105847091696 Long EC CORP US N 1 N N DEXCOM INC 549300YSK3QDSFR5EU59 DEXCOM INC 252131107 85979.00 NS USD 25616583.26 1.6262798031815 Long EC CORP US N 1 N N N MATCH GROUP INC 15OMOPB0A8K0EFUVD031 MATCH GROUP INC 57667L107 116177.00 NS USD 9152424.06 0.5810455769162 Long EC CORP US N 1 N N N BIO-TECHNE CORP 54930073RLKQ51TILZ35 BIO-TECHNE CORP 09073M104 30764.00 NS USD 11374373.72 0.7221070065015 Long EC CORP US N 1 N N N FARFETCH LTD 549300QFQ74Z0F96NS78 FARFETCH LTD 30744W107 379741.00 NS USD 3406276.77 0.2162489454144 Long EC CORP KY N 1 N N N AMERIPRISE FINANCIAL INC 6ZLKQF7QB6JAEKQS5388 AMERIPRISE FINANCIAL INC 03076C106 97813.00 NS USD 27022797.51 1.7155539195034 Long EC CORP US N 1 N N N TESLA INC 54930043XZGB27CTOV49 TESLA INC 88160R101 21642.00 NS USD 16410262.92 1.0418125977545 Long EC CORP US N 1 N N N NVIDIA CORP 549300S4KLFTLO7GSQ80 NVIDIA CORP 67066G104 343208.00 NS USD 64083797.76 4.0683874563004 Long EC CORP US N 1 N N N QUALCOMM INC H1J8DDZKZP6H7RWC0H53 QUALCOMM INC 747525103 113590.00 NS USD 16268359.80 1.0328038171641 Long EC CORP US N 1 N N N TELADOC HEALTH INC 549300I2PVFBC9MFAC61 TELADOC HEALTH INC 87918A105 333110.00 NS USD 11355719.90 0.7209227607178 Long EC CORP US N 1 N N N BILL.COM HOLDINGS INC 549300IBF9VZZIGOZW63 BILL.COM HOLDINGS INC 090043100 92268.00 NS USD 10909768.32 0.692611332906 Long EC CORP US N 1 N N N PINTEREST INC N/A PINTEREST INC 72352L106 203506.00 NS USD 3998892.90 0.2538714352476 Long EC CORP US N 1 N N N DREYFUS INSTITUTIONAL PREFERRE 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Plus Money Market Fund N/A 39544630.61 OU Other Units USD 39544630.61 2.5105078781423 Long STIV RF US N 1 2099-12-01 Variable 0.796805 N N N N N N 99VVB9HH4 N/A DREYFUS INST PREF GOVT PLUS-SL #4134 99VVB9HH4 25240805.77 OU Other Units USD 25240805.77 1.6024234076476 Long RF US N 1 N N 2022-07-27 BNY Mellon Advantage Funds, Inc. James Windels James Windels Fund Treasurer XXXX NPORT-EX 2 c10900bnymellonrese-may20221.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon Research Growth Fund, Inc.

May 31, 2022 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 95.0%

     

Automobiles & Components - 1.0%

     

Tesla

   

21,642

a 

 16,410,263

 

Capital Goods - 7.4%

     

AMETEK

   

218,726

 

26,568,647

 

Howmet Aerospace

   

566,623

 

20,268,105

 

Ingersoll Rand

   

576,509

 

27,182,399

 

Rockwell Automation

   

64,818

 

13,819,198

 

Trane Technologies

   

203,044

 

28,032,255

 
    

115,870,604

 

Commercial & Professional Services - 1.5%

     

Cintas

   

59,643

 

 23,757,596

 

Consumer Durables & Apparel - 1.6%

     

Lululemon Athletica

   

28,476

a 

8,334,640

 

Peloton Interactive, Cl. A

   

1,208,578

a,b 

16,871,749

 
    

25,206,389

 

Consumer Services - 2.3%

     

Booking Holdings

   

16,166

a 

 36,269,391

 

Diversified Financials - 1.7%

     

Ameriprise Financial

   

97,813

 

 27,022,798

 

Energy - 3.4%

     

EQT

   

1,109,676

 

 52,953,739

 

Food & Staples Retailing - 1.7%

     

Sysco

   

324,441

 

 27,311,443

 

Health Care Equipment & Services - 5.8%

     

Align Technology

   

33,307

a 

9,247,356

 

DexCom

   

85,979

a 

25,616,583

 

Edwards Lifesciences

   

257,357

a 

25,954,453

 

Intuitive Surgical

   

103,038

a 

23,455,570

 

Teladoc Health

   

228,945

a 

7,804,735

 
    

92,078,697

 

Household & Personal Products - .7%

     

The Estee Lauder Companies, Cl. A

   

42,539

 

 10,832,556

 

Materials - 2.0%

     

Alcoa

   

498,178

 

 30,747,546

 

Media & Entertainment - 9.5%

     

Alphabet, Cl. C

   

53,924

a 

122,988,781

 

Match Group

   

116,177

a 

9,152,424

 

Netflix

   

49,733

a 

9,819,284

 

The Walt Disney Company

   

68,441

a 

7,558,624

 
    

149,519,113

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 95.0% (continued)

     

Pharmaceuticals Biotechnology & Life Sciences - 8.4%

     

Bio-Techne

   

30,764

 

11,374,374

 

Danaher

   

87,299

 

23,031,222

 

Eli Lilly & Co.

   

151,886

 

47,607,148

 

Horizon Therapeutics

   

246,083

a,b 

22,071,184

 

Repligen

   

75,332

a 

12,389,854

 

Seagen

   

110,853

a 

15,040,535

 
    

131,514,317

 

Retailing - 8.2%

     

Amazon.com

   

48,749

a 

117,201,858

 

Chewy, Cl. A

   

326,550

a,b 

8,098,440

 

Farfetch, Cl. A

   

379,741

a 

3,406,277

 
    

128,706,575

 

Semiconductors & Semiconductor Equipment - 8.2%

     

Applied Materials

   

247,335

 

29,009,922

 

Marvell Technology

   

342,209

 

20,241,662

 

NVIDIA

   

343,208

 

64,083,798

 

Qualcomm

   

113,590

 

16,268,360

 
    

129,603,742

 

Software & Services - 21.3%

     

Ansys

   

73,766

a 

19,205,716

 

Bill.com Holdings

   

92,268

a 

10,909,768

 

Block

   

559,047

a,b 

48,922,203

 

CrowdStrike Holdings, CI. A

   

83,317

a 

13,329,887

 

Datadog, Cl. A

   

148,017

a 

14,119,342

 

HubSpot

   

52,776

a 

17,821,927

 

Microsoft

   

531,182

 

144,412,450

 

Salesforce

   

163,383

a 

26,180,492

 

Twilio, Cl. A

   

316,492

a 

33,285,464

 

Zoom Video Communications, CI. A

   

70,582

a 

7,584,036

 
    

335,771,285

 

Technology Hardware & Equipment - 9.6%

     

Apple

   

839,562

 

124,960,408

 

Zebra Technologies, Cl. A

   

75,332

a 

25,476,529

 
    

150,436,937

 

Transportation - .7%

     

Uber Technologies

   

499,598

a 

 11,590,674

 

Total Common Stocks (cost $1,077,167,834)

   

1,495,603,665

 
  

1-Day
Yield (%)

     

Investment Companies - 2.5%

     

Registered Investment Companies - 2.5%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional Shares
(cost $39,544,631)

 

0.80

 

39,544,631

c 

 39,544,631

 


        
 
        

Investment of Cash Collateral for Securities Loaned - 1.6%

     

Registered Investment Companies - 1.6%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, SL Shares
(cost $25,240,804)

 

0.80

 

25,240,804

c 

 25,240,804

 

Total Investments (cost $1,141,953,269)

 

99.1%

 

1,560,389,100

 

Cash and Receivables (Net)

 

.9%

 

14,775,469

 

Net Assets

 

100.0%

 

1,575,164,569

 

a Non-income producing security.

b Security, or portion thereof, on loan. At May 31, 2022, the value of the fund’s securities on loan was $32,709,424 and the value of the collateral was $35,448,154, consisting of cash collateral of $25,240,804 and U.S. Government & Agency securities valued at $10,207,350. In addition, the value of collateral may include pending sales that are also on loan.

c Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS
BNY Mellon Research Growth Fund, Inc.

May 31, 2022 (Unaudited)

The following is a summary of the inputs used as of May 31, 2022 in valuing the fund’s investments:

       
 

Level 1-Unadjusted Quoted Prices

Level 2- Other Significant Observable Inputs

 

Level 3-Significant Unobservable Inputs

Total

 

Assets ($)

  

Investments in Securities:

  

Equity Securities - Common Stocks

1,495,603,665

-

 

-

1,495,603,665

 

Investment Companies

64,785,435

-

 

-

64,785,435

 

 See Statement of Investments for additional detailed categorizations, if any.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation


purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”).These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of BNY Mellon Investment Adviser, Inc., the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by BNY Mellon Investment Adviser Inc., or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a


result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund’s rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At May 31, 2022, accumulated net unrealized appreciation on investments was $418,435,831, consisting of $634,652,783 gross unrealized appreciation and $216,216,952 gross unrealized depreciation.

At May 31, 2022, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.